Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBMG | LCTX | ALLO | ||
| Company | Cellular Biomedicine | Lineage Cell Therapeutics Inc | Allogene Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 19.74 | 1.6900 | 1.7000 | ||
| High | 19.75 | 1.7134 | 1.7200 | ||
| Low | 19.73 | 1.6500 | 1.6000 | ||
| Latest | 19.75 | 1.6500 | 1.6100 | ||
| Change | unch | -0.0500 | -0.0900 | ||
| % Change | unch | -2.94% | -5.29% | ||
| Volume | 171,900 | 697,092 | 5,618,562 | ||
| 20-Day Average Volume | 197,580 | 1,225,845 | 4,114,953 | ||
| Previous Close | 19.75 | 1.7000 | 1.7000 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 19.27 | 1.6965 | 1.4675 | ||
| 20-Day Raw Stochastic | 99.77% | 28.85% | 53.85% | ||
| 20-Day Relative Strength | 67.50 | 47.31 | 58.10 | ||
| Weighted Alpha | +21.75 | +127.34 | +11.84 | ||
| Today's Opinion | 100% Buy | 48% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 48% Buy | 100% Buy | ||
| Last Month's Opinion | 8% Sell | 56% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 02/11/21 | -6.25% since 01/08/26 | +8.05% since 01/08/26 | ||
| Low | 19.68 on 02/12/21 | 1.6350 on 01/12/26 | 1.6000 on 01/15/26 | ||
| High | 19.75 on 02/18/21 | 1.7850 on 01/12/26 | 1.8800 on 01/09/26 | ||
| 1-Month | |||||
| %Chg | +8.76% since 01/19/21 | -4.07% since 12/15/25 | +9.52% since 12/15/25 | ||
| Low | 17.60 on 01/28/21 | 1.5750 on 12/30/25 | 1.2950 on 12/30/25 | ||
| High | 19.75 on 02/18/21 | 1.8350 on 01/07/26 | 1.8800 on 01/09/26 | ||
| 3-Month | |||||
| %Chg | +7.63% since 11/19/20 | -8.84% since 10/15/25 | +26.77% since 10/15/25 | ||
| Low | 17.60 on 01/28/21 | 1.5300 on 11/07/25 | 1.0400 on 11/07/25 | ||
| High | 19.75 on 02/18/21 | 2.0900 on 11/03/25 | 1.8800 on 01/09/26 | ||
| 6-Month | |||||
| %Chg | +7.57% since 08/19/20 | +65.00% since 07/15/25 | +29.84% since 07/15/25 | ||
| Low | 16.98 on 11/06/20 | 0.9296 on 07/22/25 | 0.9842 on 08/07/25 | ||
| High | 19.75 on 02/18/21 | 2.0900 on 11/03/25 | 1.8800 on 01/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 384,691 | 391,558 | 382,041 | ||
| Shares Outstanding, K | 19,478 | 230,328 | 224,730 | ||
| Annual Sales | 340,000 | 9,500,000 | 20,000 | ||
| Annual Net Income | -49,980,000 | -18,610,000 | -257,590,000 | ||
| Last Quarter Sales | 30,000 | 3,680,000 | 0 | ||
| Last Quarter Net Income | -17,040,000 | -29,780,000 | -41,400,000 | ||
| 60-Month Beta | 1.17 | 1.74 | 0.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.13 on 11/06/25 | -0.19 on 11/06/25 | ||
| Latest Earnings Date | 02/26/21 | 03/09/26 | 03/12/26 | ||
| Most Recent Dividend | N/A | 0.080 on 12/15/03 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||